Sai Life Science Ltd

NSE: SAILIFE · BSE: 544306 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹1,592.20
Market cap: ₹33,821 Cr
Revenue (annual): ₹2,192 Cr
Net profit (annual): ₹348.9 Cr
P/E (TTM): 93.5×Sector 50.4×
Promoter holding: 34.53%-0.08% QoQ
FII holding: 19.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Financial Results 2 Employee Stock Options 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Aug 2026 13:48 IST BSE

Earnings Call

Sai Life Science Investor Presentation: Key Takeaways

Sai Life Sciences delivered strong Q1FY27 performance with revenue of ₹554 Cr, up 12% YoY, and PAT of ₹73 Cr, up 22% YoY, driven by growth in CRO and CDMO segments.

Call: Guides 20% growth

Open call summary → Read the filing ↗

21 May 2026 14:10 IST BSE

Earnings Call

Sai Life Science Earnings Call: Key Takeaways

Sai Life Sciences reported robust FY26 performance with 29% revenue growth and 109% PAT growth, driven by deepening engagement with 19 of top 25 global pharma companies.

Open call summary → Read the filing ↗

15 May 2026 14:24 IST BSE

Earnings Call

Sai Life Science Earnings Call: Key Takeaways

Sai Life Sciences delivered strong FY26 performance with 29% revenue growth and 56% EBITDA growth, driven by expansion in CDMO and CRO segments and improved operating leverage.

Open call summary → Read the filing ↗